PS-341 in Treating Women With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: bortezomib
Sponsor: Northwestern University
Collaborators: National Cancer Institute (NCI)